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Abstract
Following the submission of application EFSA-GMO-RX-007 under Regulation (EC) No 1829/2003 from
Monsanto, the Panel on Genetically Modiﬁed Organisms of the European Food Safety Authority (GMO
Panel) was asked to deliver a scientiﬁc risk assessment on the data submitted in the context of the
renewal of authorisation application of the herbicide-tolerant and insect-resistant genetically modiﬁed
maize NK603 x MON810. The data received in the context of this renewal application contained
post-market environmental monitoring reports, a systematic search and evaluation of literature,
updated bioinformatic analyses, and additional documents or studies performed by or on behalf of the
applicant. The GMO Panel assessed these data for possible new hazards, modiﬁed exposure or new
scientiﬁc uncertainties identiﬁed during the authorisation period and not previously assessed in the
context of the original application. Under the assumption that the DNA sequence of the events in maize
NK603 x MON810 considered for renewal is identical to the sequence of the originally assessed events,
the GMO Panel concludes that there is no evidence in the renewal application EFSA-GMO-RX-007 for
new hazards, modiﬁed exposure or scientiﬁc uncertainties that would change the conclusions of the
original risk assessment on maize NK603 x MON810.
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Summary
Following the submission of application EFSA-GMO-RX-007 under Regulation (EC) No 1829/20031
from Monsanto, the Panel on Genetically Modiﬁed Organisms of the European Food Safety Authority
(GMO Panel) was asked to deliver a scientiﬁc opinion on the data submitted in the context of the
renewal of authorisation application of the herbicide-tolerant and insect-resistant genetically modiﬁed
(GM) maize NK603 x MON810. The scope of the renewal application EFSA-GMO-RX-007 is for food and
feed uses, import and processing, but excludes cultivation within the European Union (EU).
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-RX-007,
additional information provided by the applicant, scientiﬁc comments submitted by the Member States
and relevant scientiﬁc publications. The data received in the context of the renewal application EFSA-
GMO-RX-007 contained: post-market environmental monitoring reports, an evaluation of the literature
retrieved by a systematic search, updated bioinformatic analyses and additional documents or studies
performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new
hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation period
and not previously assessed in the context of the original application.
Under the assumption that the DNA sequence of the events in maize NK603 x MON810 considered
for renewal is identical to the sequence of the originally assessed events, the GMO Panel concludes
that there is no evidence in the renewal application EFSA-GMO-RX-007 for new hazards, modiﬁed
exposure or scientiﬁc uncertainties that would change the conclusions of the original risk assessment
on maize NK603 x MON810.
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
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1. Introduction
1.1. Background
On 22 December 2016, the European Food Safety Authority (EFSA) received from the European
Commission (DG SANTE) the application EFSA-GMO-RX-007 by Monsanto for the renewal of
authorisation of genetically modiﬁed (GM) maize NK603 x MON810 (maize MON-ØØ6Ø3-6 x MON-
ØØ81Ø-6) for food and feed uses, import and processing within the framework of Regulation (EC)
No 1829/2003. Before sending the application to EFSA, the European Commission (DG SANTE)
conﬁrmed whether the data submitted in the context of this renewal application were in line with the
legal requirements laid down in Articles 11 and 23 of Regulation (EC) No 1829/2003.
After receiving the application EFSA-GMO-RX-007, and in accordance with Articles 5(2)(b) and 17(2)
(b) of Regulation (EC) No 1829/2003, EFSA informed Member States and made the summary of the
application available to the public on the EFSA website.2
On 18 April 2017, EFSA declared the application valid in accordance with Articles 6(1) and 18(1) of
Regulation (EC) No 1829/2003. EFSA made the valid application available to Member States and the
European Commission, and consulted nominated risk assessment bodies of Member States, including
national Competent Authorities within the meaning of Directive 2001/18/EC following the requirements
of Articles 6(4) and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. Member
States had 3 months after the opening of the Member State commenting period (until 1 August 2017)
to make their opinion known.
Following the submission of application EFSA-GMO-UK-2004-01 and the publication of the EFSA
scientiﬁc opinion (EFSA, 2005), the placing on the market of maize NK603 x MON810 for food/feed
uses, except cultivation, was authorised by Commission Decision 2007/701/EC.3 A copy of this
authorisation was provided by the applicant.4
EFSA requested additional information on 12 July 2017 and 28 November, and the applicant
submitted the replies on 13 September 2017 and 11 January 2018, respectively. On 5 October, EFSA
received from the European Commission the post-market environmental monitoring plan submitted by
the applicant to the risk managers.
In giving its scientiﬁc opinion to the European Commission, the Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application.
As additional information was requested by the GMO Panel, the time limit of 6 months was extended
accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc risk assessment on the data submitted in the
context of a renewal of authorisation application for maize NK603 x MON810 for food and feed uses,
import and processing in accordance with Articles 11 and 23 of Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of GMOs or food/feed
containing or consisting of GMOs, conditions for the protection of particular ecosystems/environment
and/or geographical areas, should be indicated in accordance with Articles 6(5)(e) and 18(5)(e) of
Regulation (EC) No 1829/2003.
The GMO Panel was not requested to give an opinion on information required under Annex II to
the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation events in
the food/feed and/or food/feed produced from it), which are matters related to risk management.
2 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2017-00028
3 Commission Decision of 24 October 2007 authorising the placing on the market of products containing, consisting of, or
produced from genetically modiﬁed maize NK603 x MON810 (maize MON-ØØ6Ø3-6xMON-ØØ81Ø-6) pursuant to Regulation
(EC) No 1829/2003 of the European Parliament and of the Council. (2007/701/EC); OJ L 285, pp 37–41.
4 Annex 1 of the dossier.
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2. Data and methodologies
2.1. Data
The data for application EFSA-GMO-RX-007 provided by the applicant at the time of submission, or
in reply to requests for additional information, are speciﬁed below.
No new sequencing data were submitted among the studies performed by or on behalf of the
applicant. Therefore, in accordance with the GMO Panel guidelines for renewal of applications of GM
food/feed authorised under Regulation (EC) No 1829/2003 (EFSA GMO Panel, 2015), the GMO
Panel evaluated the data provided in the context of NK603 x MON810 renewal application under the
assumption that the events’ sequence is identical to the sequence of the originally assessed events.
In addition the GMO Panel noted that the assumption was supported by information on the
sequence of event NK603 in commercial varieties of maize NK603 x MON810 that has been published
(Castan et al., 2017). The applicant has conﬁrmed that the NK603 sequence in NK603 x MON810
commercial varieties is identical to that of the original event (EFSA, 2005, 2009).5
2.1.1. Post-market monitoring reports6
Based on the outcome of the initial food and feed risk assessment, a post-market monitoring plan
for monitoring of GM food/feed was not required by the authorisation decision. The implementation of
a post-market environmental monitoring (PMEM) plan, consisting of a general surveillance plan to
check for any adverse effects on the environment arising from maize NK603 x MON810, was a
condition for the authorisation. As no potential adverse environmental effects were identiﬁed in the
environmental risk assessment (ERA) of maize NK603 x MON810 (EFSA, 2005), case-speciﬁc
monitoring was not considered necessary by the GMO Panel.
The applicant provided eight annual PMEM reports covering a reporting period from March 2008 to
July 2016. The annual PMEM plans submitted by the applicant included (1) the description of a
centralised system established by EuropaBio for the collection of information recorded by various
operators (federations involved in maize (or bulk grain) import and processing) on any observed
adverse effect(s) on human health and the environment arising from handling of maize possibly
containing maize NK603 x MON810; (2) the reports of the surveillance activities conducted by such
operators; and (3) the review of relevant scientiﬁc peer-reviewed studies retrieved from literature
searches.
2.1.2. Systematic search and evaluation of literature7
The applicant performed a systematic literature search of studies published between 2007 and
2016, relevant to the food/feed and environmental safety assessments of maize NK603 x MON810,
following the principles outlined in the EFSA guidance on the application of systematic review
methodology for food and feed safety assessment (EFSA, 2010). In total, 28 publications using the
identiﬁed search terms relevant to maize NK603 x MON810 were identiﬁed. After applying the
eligibility/inclusion criteria deﬁned a priori by the applicant, no primary research studies were identiﬁed
that was relevant for the food and feed risk assessment, and the ERA risk assessment.
2.1.3. Updated bioinformatic data8
At the time of submission of the renewal dossier, the applicant provided a bioinformatics data
package for maize NK603 x MON810 including an analysis of the insert and ﬂanking sequences and an
analysis of the potential similarity to allergens or toxins of the newly expressed proteins and of all
possible open reading frames (ORFs) within the insert and spanning the junction sites and an analysis
of possible horizontal gene transfer (HGT). The bioinformatic data were obtained using the original
sequence submitted by the applicant. The outcome of the updated bioinformatics is presented in
Section 3.3.
5 Additional information 11/1/2018.
6 Annex 2 of the dossier.
7 Annex 3.1 of the dossier.
8 Annex 3.2 of the dossier and additional information 13/9/2017.
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2.1.4. Additional documents or studies provided by the applicant9
The applicant provided an overview on the worldwide approvals of maize NK603 x MON810 and the
full reports of all studies performed by or on behalf of the applicant over the course of the
authorisation period and not previously submitted to the EU (Appendix A).
The relevance of the listed studies for molecular characterisation, human and animal safety and the
environment was assessed by the applicant.
2.1.5. Overall assessment as provided by the applicant10
In line with the requirements listed in the renewal guidance (EFSA GMO Panel, 2015), the applicant
provided an overall assessment concluding that information provided in the application for renewal of
the authorisation of maize NK603 x MON810 for food and feed use and processing in the EU, do not
change the outcome of the original risk assessment (EFSA, 2005).
2.1.6. Monitoring plan and proposal for improving the conditions of the original
authorisation11
The applicant indicated in the dossier that the environmental monitoring plan is appropriate and
does not need any changes.
2.2. Methodologies
The GMO Panel assessed the application for the renewal of the authorisation of maize
NK603 x MON810 for food and feed uses, import and processing in accordance with Articles 11 and 23
of Regulation (EC) No 1829/2003. The GMO Panel took into account the requirements described in its
guideline for the risk assessment of renewal applications of GM food and feed authorised under
Regulation (EC) No 1829/2003 (EFSA GMO Panel, 2015).
The comments raised by Member States are addressed in Annex G of EFSA’s overall opinion12 and
were taken into consideration during the scientiﬁc risk assessment.
3. Assessment
3.1. Evaluation of the post-market environmental monitoring reports
During the general surveillance activities covering the authorisation period of maize
NK603 x MON810, no adverse effects were reported by the applicant.
3.2. Evaluation of the systematic search and evaluation of literature
The GMO Panel assessed the systematic literature search carried out by the applicant and
acknowledged that no publication has been identiﬁed raising a safety concern for human and animal
health and the environment which would change the original risk assessment conclusions on maize
NK603 x MON810 (EFSA, 2005).
Due to the date of the publication, the publication by Castan et al. (2017) was not included in the
systematic literature search. This publication is discussed in Section 2.1
3.3. Evaluation of the updated bioinformatic data
The results of the updated bioinformatic analyses on maize events NK603 and MON810 conﬁrmed
previous assessments (EFSA, 2005) that no known endogenous genes were disrupted by the inserts.
Analyses of the amino acid sequence of the newly expressed CP4 EPSPS and Cry1Ab proteins revealed
no signiﬁcant similarities to toxins and allergens. In addition, bioinformatic analyses of the newly
created ORFs within the insert or spanning the junctions with genomic DNA revealed no signiﬁcant
similarities to toxins and allergens.
The sequence identity analysis of the regions of bacterial origin in maize NK603 x MON810 did not
identify elements with sufﬁcient length and identity to support homologous recombination. There is no
9 Annex 3.3 of the dossier and additional information: 6/7/2017.
10 Annex 3 of the dossier.
11 Additional information: 5/10/2017.
12 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2017-00028
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information that would change the previous conclusion of the GMO Panel that the unlikely, but
theoretically possible, horizontal transfer of recombinant genes from maize NK603 x MON810 to
bacteria does not raise any environmental safety concern.
3.4. Evaluation of the additional documents or studies provided by the
applicant
The GMO Panel evaluated the full reports of the additional studies provided and listed in Appendix A.
This new information did not raise any concern for human and animal health and the environment,
which would change the original risk assessment conclusions on maize NK603 x MON810.
3.5. Evaluation of the overall assessment as provided by the applicant
The GMO Panel evaluated the overall assessment provided by the applicant and conﬁrmed that
there is no evidence in the renewal application EFSA-GMO-RX-007 indicating new hazards, relevant
changes in exposure or scientiﬁc uncertainties.
3.6. Evaluation of the monitoring plan and proposal for improving the
conditions of the original authorisation
The PMEM plan followed by the applicant consists mainly of general surveillance of imported GM
maize plant material, including maize NK603 x MON810.11 This general surveillance is coordinated by
EuropaBio and implemented by selected operators (federations involved in maize import and
processing). As mentioned in Section 2.1.6, the applicant considers that this plan does not need any
changes. The GMO Panel is of the opinion that the scope of the plan provided by the applicant is
consistent with the scope of maize NK603 x MON810 but reminds that monitoring is related to risk
management, and thus the ﬁnal adoption and implementation of the PMEM plan falls outside the
mandate of EFSA.
4. Conclusions
Under the assumption that the DNA sequence of the two events in maize NK603 x MON810
considered for renewal is identical to the sequence of the originally assessed events, the GMO
Panel concludes that there is no evidence in the renewal application EFSA-GMO-RX-007 for new
hazards, modiﬁed exposure or scientiﬁc uncertainties that would change the conclusions of the original
risk assessment on maize NK603 x MON810 (EFSA, 2005).
Documentation provided to EFSA
1) Letter from the European Commission to EFSA received on 22 December 2016 for the
continued marketing of genetically modiﬁed maize NK603 x MON810 in accordance with
articles 11 and 23 of Regulation (EC) No 1829/2003 by Monsanto (EFSA-GMO-RX-007).
2) Acknowledgement letter dated 11 January 2017 from EFSA to European Commission.
3) Letter from EFSA to applicant dated 20 February 2017 requesting additional information
under completeness check.
4) Letter from applicant to EFSA received on 23 March 2017 providing additional information
under completeness check.
5) Letter from EFSA to applicant dated 18 April 2017 delivering the ‘Statement of Validity’ for
application EFSA-GMO-RX-007.
6) Letter from EFSA to applicant dated 12 July 2017 requesting additional information and
stopping the clock.
7) Letter from applicant to EFSA received on 13 September 2017 providing additional
information.
8) Email from EFSA to applicant dated 14 September 2017 re-starting the clock on
6 July 2017.
9) Letter from the European Commission to EFSA received on 5 October 2017 providing the
post-market environmental monitoring plans submitted by Monsanto.
10) Letter from EFSA to applicant dated 28 November 2017 requesting additional information
and stopping the clock.
11) Letter from applicant to EFSA received on 11 January 2018 providing additional information.
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Abbreviations
EPSPS 5-enolpyruvylshikimate-3-phosphate synthase
ERA environmental risk assessment
GM genetically modiﬁed
GMO genetically modiﬁed organisms
HGT horizontal gene transfer
ORFs open reading frames
PMEM post-market environmental monitoring report
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Appendix A – List of additional studies performed by or on behalf of the
applicant over the course of the authorisation period and not previously
submitted to the EU with regard to the evaluation of the safety of the
food/feed for humans, animal or the environment from maize
NK603 x MON810
Study identiﬁcation Title
Report N°:
MSL0021504
Compositional Analyses of Corn Forage and Grain from NK603, MON 810 x NK603,
MON 88017, MON 89034, MON 89034 x MON 88017, and MON 89034 x NK603 Produced
in European Field Trials during the 2007 Growing Season
Report N°:
MSL0020890
Assessment of the Cry1Ab and CP4 EPSPS Protein Levels in Tissues from Maize
MON 810 x NK603 Produced in 2005–2006 Brazil Field Trials
Report N°:
RAR-09-204
Compositional Analysis of Grain from RSA Maize (MON 810 x NK603 and NK603) and
Conventional Maize Produced in Republic of South Africa during 2009
Report N°:
MSL0021367
Assessment of the CP4 EPSPS and Cry1Ab Protein Levels in Tissues of Corn
NK603 x MON 810 Produced in European Field Trials During 2007
Report N°:
MSL0020739
Compositional Analyses of Forage and Grain Collected from Maize MON 810 x NK603
Grown in 2005–2006 Brazil Field Trials
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